195 related articles for article (PubMed ID: 1192421)
1. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
Pierce GE; DeVald B
Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
[TBL] [Abstract][Full Text] [Related]
2. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
Yasumoto K; Ohta M; Nomoto K
Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
Stiller-Winkler R; Stark M; Idel H
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
Pierce GE; Allingham R; Bell JW
Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
[No Abstract] [Full Text] [Related]
6. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
[TBL] [Abstract][Full Text] [Related]
8. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
9. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
[TBL] [Abstract][Full Text] [Related]
10. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
11. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
12. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
Piacentini G; Ferrari S; Megale C; Ippoliti F
Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
[No Abstract] [Full Text] [Related]
13. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
[TBL] [Abstract][Full Text] [Related]
14. Effects of human lymphocytes on cultured normal and malignant cells.
Pierce GE; DeVald BL
Cancer Res; 1975 Jul; 35(7):1830-9. PubMed ID: 805664
[TBL] [Abstract][Full Text] [Related]
15. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
17. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
Brugarolas A; Han T; Takita H; Minowada J
N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
[No Abstract] [Full Text] [Related]
18. Effects of human sera on reactivity of lymphocytes in microcytotoxicity assays.
Pierce GE; DeVald BL
Cancer Res; 1975 Oct; 35(10):2729-37. PubMed ID: 1157047
[TBL] [Abstract][Full Text] [Related]
19. Immunocytology of cancer.
Davidsohn I; Ni LY
Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
[No Abstract] [Full Text] [Related]
20. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]